Key Takeaways
- • The Competition Commission of India (CCI) approved on Saturday, November 14, 2026, the acquisition of a shareholding in Yatharth Hospital & Trauma Care Services Limited by Rasmalai Limited, according to an official CCI release reported by ANI.
- • Rasmalai Limited is incorporated in Cyprus, is primarily engaged in holding investments, and has no current business operations or presence in India.
- • Rasmalai is indirectly controlled by investment funds managed or advised by global private equity firm Advent International, L.P. and/or its affiliates.
- • The CCI release did not disclose the percentage of shareholding to be acquired or the transaction's financial value.
- • The approval clears the transaction from the competition regulator's perspective.
Summary
According to the CCI, Rasmalai Limited is incorporated in Cyprus and is primarily engaged in holding investments. The company currently has no business operations or presence in India. The regulator stated that the acquirer is indirectly controlled by investment funds managed and/or advised by Advent International, L.P. and/or its affiliates, identifying the global private equity firm as the ultimate backer of the buyer.
Yatharth Hospital & Trauma Care Services Limited operates a network of super-speciality hospitals in India, offering healthcare services, diagnostic facilities and advanced medical procedures across multiple medical specialities. The target is therefore a provider of hospital and diagnostic services within the Indian healthcare sector.
The CCI release did not disclose the percentage of shareholding proposed to be acquired or the financial value of the transaction, so the size of the stake and the deal price remain unreported in the regulator's announcement.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.